-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Precigen, Raises Price Target to $9

Benzinga·03/26/2026 13:07:27
Listen to the news
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $8 to $9.